Robert Provenzano

3.0k total citations
65 papers, 2.2k citations indexed

About

Robert Provenzano is a scholar working on Hematology, Nephrology and Genetics. According to data from OpenAlex, Robert Provenzano has authored 65 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 24 papers in Nephrology and 17 papers in Genetics. Recurrent topics in Robert Provenzano's work include Erythropoietin and Anemia Treatment (30 papers), Dialysis and Renal Disease Management (22 papers) and Hemoglobinopathies and Related Disorders (17 papers). Robert Provenzano is often cited by papers focused on Erythropoietin and Anemia Treatment (30 papers), Dialysis and Renal Disease Management (22 papers) and Hemoglobinopathies and Related Disorders (17 papers). Robert Provenzano collaborates with scholars based in United States, United Kingdom and Poland. Robert Provenzano's co-authors include Thomas B. Neff, Anatole Besarab, Stefan Hemmerich, Robert Leong, Kin-Hung P. Yu, Lynda A. Szczech, Raja I. Zabaneh, Tyson Lee, Allan J. Collins and Sharon Andreoli and has published in prestigious journals such as New England Journal of Medicine, Blood and Journal of the American Society of Nephrology.

In The Last Decade

Robert Provenzano

64 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Provenzano United States 24 1.2k 819 500 309 213 65 2.2k
Iain C. Macdougall United Kingdom 35 2.7k 2.3× 1.1k 1.3× 1.2k 2.4× 109 0.4× 253 1.2× 83 3.8k
EJ Lee United States 20 941 0.8× 119 0.1× 163 0.3× 39 0.1× 388 1.8× 82 2.0k
Rebecca Cardigan United Kingdom 31 1.1k 0.9× 84 0.1× 304 0.6× 73 0.2× 299 1.4× 119 2.9k
Ashley Irish Australia 33 326 0.3× 814 1.0× 129 0.3× 55 0.2× 247 1.2× 115 2.6k
Hanny Al‐Samkari United States 31 1.6k 1.3× 72 0.1× 933 1.9× 57 0.2× 275 1.3× 193 3.8k
Peter Hellstern Germany 28 1.1k 0.9× 48 0.1× 287 0.6× 83 0.3× 176 0.8× 115 2.6k
Ted Wun United States 28 684 0.6× 31 0.0× 626 1.3× 142 0.5× 225 1.1× 75 2.9k
Andrew J. Innes United Kingdom 21 218 0.2× 512 0.6× 110 0.2× 22 0.1× 214 1.0× 84 1.3k
Isabel Graupera Spain 33 213 0.2× 472 0.6× 109 0.2× 143 0.5× 323 1.5× 94 4.1k
Sabine Ziemer Germany 24 465 0.4× 138 0.2× 68 0.1× 27 0.1× 172 0.8× 86 1.7k

Countries citing papers authored by Robert Provenzano

Since Specialization
Citations

This map shows the geographic impact of Robert Provenzano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Provenzano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Provenzano more than expected).

Fields of papers citing papers by Robert Provenzano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Provenzano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Provenzano. The network helps show where Robert Provenzano may publish in the future.

Co-authorship network of co-authors of Robert Provenzano

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Provenzano. A scholar is included among the top collaborators of Robert Provenzano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Provenzano. Robert Provenzano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pollock, Carol A., Robert Provenzano, Anjay Rastogi, et al.. (2021). Roxadustat in Elderly Patients with Anemia of CKD. Journal of the American Society of Nephrology. 32(10S). 182–182. 1 indexed citations
2.
Rastogi, Anjay, Roberto Pecoits‐Filho, Steven Fishbane, et al.. (2020). Roxadustat Treatment Corrects Anemia to Hemoglobin (Hb) Values ≥10 g/dL in the Majority of Patients with Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD). Journal of the American Society of Nephrology. 31(10S). 133–133. 1 indexed citations
3.
Provenzano, Robert, Steven Fishbane, Daniel W. Coyne, et al.. (2020). Roxadustat Treatment of Anemia in Non-Dialysis-Dependent CKD Is Not Influenced by Iron Status. Journal of the American Society of Nephrology. 31(10S). 1–1. 1 indexed citations
4.
Fishbane, Steven, Brigitte Schiller, Francesco Locatelli, et al.. (2013). Peginesatide in Patients with Anemia Undergoing Hemodialysis. New England Journal of Medicine. 368(4). 307–319. 69 indexed citations
5.
Macdougall, Iain C., Robert Provenzano, Amit Sharma, et al.. (2013). Peginesatide for Anemia in Patients with Chronic Kidney Disease Not Receiving Dialysis. New England Journal of Medicine. 368(4). 320–332. 78 indexed citations
6.
Roger, Simon D., Francesco Locatelli, Rainer P. Woitas, et al.. (2011). C.E.R.A. once every 4 weeks corrects anaemia and maintains haemoglobin in patients with chronic kidney disease not on dialysis. Nephrology Dialysis Transplantation. 26(12). 3980–3986. 39 indexed citations
7.
Provenzano, Robert, Brigitte Schiller, Madhumathi Rao, et al.. (2009). Ferumoxytol as an Intravenous Iron Replacement Therapy in Hemodialysis Patients. Clinical Journal of the American Society of Nephrology. 4(2). 386–393. 145 indexed citations
8.
Wyck, David Van, et al.. (2009). Relationship among Length of Facility Ownership, Clinical Performance, and Mortality. Clinical Journal of the American Society of Nephrology. 5(2). 248–251. 8 indexed citations
9.
Macdougall, Iain C., Rowan G. Walker, Robert Provenzano, et al.. (2008). C.E.R.A. Corrects Anemia in Patients with Chronic Kidney Disease not on Dialysis. Clinical Journal of the American Society of Nephrology. 3(2). 337–347. 79 indexed citations
10.
Wish, Jay B., et al.. (2008). Postdialysis outcomes associated with consistent anemia treatment in predialysis patients with chronic kidney disease. Clinical Nephrology. 69(4). 251–259. 4 indexed citations
11.
Levey, Andrew S., Sharon Andreoli, Thomas D. DuBose, Robert Provenzano, & Allan J. Collins. (2007). Chronic Kidney Disease. Journal of the American Society of Nephrology. 18(2). 374–378. 51 indexed citations
12.
Provenzano, Robert, et al.. (2005). Extended epoetin alfa dosing as maintenance treatment for the anemia of chronic kidney disease: the PROMPT study. Clinical Nephrology. 64(8). 113–123. 68 indexed citations
13.
Provenzano, Robert, et al.. (2004). Once-weekly epoetin alfa for treating the anemia of chronic kidney disease. Clinical Nephrology. 61(6). 392–405. 56 indexed citations
14.
Henry, David H., et al.. (2004). Epoetin Alfa. Archives of Internal Medicine. 164(3). 262–262. 78 indexed citations
15.
Provenzano, Robert. (2003). Treating chronic kidney disease.. PubMed. Spec No. 3–7; discussion 17. 2 indexed citations
16.
Provenzano, Robert, et al.. (2000). Effect of biocompatibility of hemodialysis membranes on serum albumin levels. American Journal of Kidney Diseases. 35(4). 606–610. 24 indexed citations
17.
18.
Khairullah, Quresh, et al.. (1999). Extraskeletal Ewing's sarcoma in a kidney transplant patient. American Journal of Kidney Diseases. 33(6). 1164–1167. 11 indexed citations
19.
Provenzano, Robert, et al.. (1998). Two low‐dose OKT3 induction regimens following renal transplantation – clinical experience at a single center. Clinical Transplantation. 12(4). 343–347. 6 indexed citations
20.
Latif, Sajid, et al.. (1997). Pulmonary mucormycosis in diabetic renal allograft recipients. American Journal of Kidney Diseases. 29(3). 461–464. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Iain C. Macdougall Breakdown of academic impact, for papers by EJ Lee Breakdown of academic impact, for papers by Rebecca Cardigan Breakdown of academic impact, for papers by Ashley Irish Breakdown of academic impact, for papers by Hanny Al‐Samkari Breakdown of academic impact, for papers by Peter Hellstern Breakdown of academic impact, for papers by Ted Wun Breakdown of academic impact, for papers by Andrew J. Innes Breakdown of academic impact, for papers by Isabel Graupera Breakdown of academic impact, for papers by Sabine Ziemer
Rankless by CCL
2026